Cargando…

Intravenous Iron Supplementation Practices and Short-Term Risk of Cardiovascular Events in Hemodialysis Patients

BACKGROUND & OBJECTIVES: Intravenous iron supplementation is widespread in the hemodialysis population, but there is uncertainty about the safest dosing strategy. We compared the safety of different intravenous iron dosing practices on the risk of adverse cardiovascular outcomes in a large popul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kshirsagar, Abhijit V., Freburger, Janet K., Ellis, Alan R., Wang, Lily, Winkelmayer, Wolfgang C., Brookhart, M. Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815308/ https://www.ncbi.nlm.nih.gov/pubmed/24223866 http://dx.doi.org/10.1371/journal.pone.0078930

Ejemplares similares

Comparative short-term safety of bolus versus maintenance iron dosing in hemodialysis patients: a replication study
por: Freburger, Janet K, et al.
Publicado: (2014)

Options for intravenous iron supplementation in hemodialysis patients
por: Kong, Ji Yoon, et al.
Publicado: (2020)

QT-Prolonging Antibiotics, Serum-to-Dialysate Potassium Gradient, and Risk of Sudden Cardiac Death Among Patients Receiving Maintenance Hemodialysis
por: Pun, Patrick H., et al.
Publicado: (2023)

Dynamics of cinacalcet use and biochemical control in hemodialysis patients: a retrospective New-user cohort design
por: Reams, B. Diane, et al.
Publicado: (2015)

Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients
por: Brunelli, Steven M, et al.
Publicado: (2018)

Effects of short-term ambient PM(2.5) exposure on cardiovascular disease incidence and mortality among U.S. hemodialysis patients: a retrospective cohort study
por: Xi, Yuzhi, et al.
Publicado: (2022)

Associations of Glycemic Control With Cardiovascular Outcomes Among US Hemodialysis Patients With Diabetes Mellitus
por: Rhee, Jinnie J., et al.
Publicado: (2017)

PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism
por: Akizawa, Tadao, et al.
Publicado: (2016)

Effect of short-term intravenous ascorbic acid on reducing ferritin in hemodialysis patients
por: Jalalzadeh, M., et al.
Publicado: (2012)

Iron Administration, Infection, and Anemia Management in CKD: Untangling the Effects of Intravenous Iron Therapy on Immunity and Infection Risk
por: Ganz, Tomas, et al.
Publicado: (2020)

Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End‐Stage Kidney Disease
por: Assimon, Magdalene M., et al.
Publicado: (2020)

Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients
por: Kuo, Ko-Lin, et al.
Publicado: (2012)

Correction: Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients
por: Kuo, Ko-Lin, et al.
Publicado: (2013)

Intravenous iron supplementation does not increase infectious disease risk in hemodialysis patients: a nationwide cohort-based case-crossover study
por: Yen, Chieh-Li, et al.
Publicado: (2019)

Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study
por: Peters, N. O., et al.
Publicado: (2017)

Comparative Study of Intravenous Iron Versus Intravenous Ascorbic Acid for Treatment of Functional Iron Deficiency in Patients Under Hemodialysis: A Randomized Clinical Trial
por: Sedighi, Omid, et al.
Publicado: (2013)

Intravenous iron therapy and the cardiovascular system: risks and benefits
por: Del Vecchio, Lucia, et al.
Publicado: (2020)

Randomized double-blind safety comparison of intravenous iron dextran versus iron sucrose in an adult non-hemodialysis outpatient population: A feasibility study
por: Louzada, Martha L., et al.
Publicado: (2016)

Effect of Intravenous Iron Supplementation on Iron Stores in Non-Anemic Iron-Deficient Patients with Hereditary Hemorrhagic Telangiectasia
por: Karlsson, Torbjörn, et al.
Publicado: (2016)

Soluble Klotho is associated with mortality and cardiovascular events in hemodialysis
por: Memmos, Evangelos, et al.
Publicado: (2019)

Cardiovascular Response to Intravenous Glucose Injection during Hemodialysis with Assessment of Entropy Alterations
por: Niemczyk, Longin, et al.
Publicado: (2022)

Impact of sarcopenia on long-term mortality and cardiovascular events in patients undergoing hemodialysis
por: Kim, Jwa-Kyung, et al.
Publicado: (2019)

The impact of intravenous iron supplementation in elderly patients undergoing major surgery
por: Blum, Lea Valeska, et al.
Publicado: (2022)

The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data
por: Pollak, Victor E, et al.
Publicado: (2009)

Cardiovascular Events in Hemodialysis Patients: Challenging against Vascular Calcification
por: Kobayashi, Shuzo
Publicado: (2017)

What is the relationship between sclerostin and cardiovascular events in hemodialysis patients?
por: Zhao, Yu, et al.
Publicado: (2020)

Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States
por: McGrath, Leah J., et al.
Publicado: (2018)

An Analysis of Vascular Access Thrombosis Events From the Proactive IV irOn Therapy in hemodiALysis Patients Trial
por: Thomson, Peter C., et al.
Publicado: (2022)

Maintenance intravenous iron in hemodialysis patients to minimize erythropoietin doses: a double-blinded, randomized controlled trial (the MAINTAIN IRON trial)
por: Anumas, Suthiya, et al.
Publicado: (2023)

Hemodialysis Versus Peritoneal Dialysis Drug Expenditures: A Comparison Within the Private Insurance Market
por: Bhatnagar, Anshul, et al.
Publicado: (2023)

Changes of biomarkers for erythropoiesis, iron metabolism, and FGF23 by supplementation with roxadustat in patients on hemodialysis
por: Yoshida, Shunsuke, et al.
Publicado: (2023)

A Randomized Trial of Intravenous Iron Supplementation and Exercise on Exercise Capacity in Iron-Deficient Nonanemic Patients With CKD
por: Greenwood, Sharlene A., et al.
Publicado: (2023)

Short‐Term Change in eGFR and Risk of Cardiovascular Events
por: Turin, Tanvir Chowdhury, et al.
Publicado: (2014)

Association of short-term blood pressure variability with cardiovascular mortality among incident hemodialysis patients
por: Feng, Yiduo, et al.
Publicado: (2018)

Comparison of short-term efficacy of iron sucrose with those of ferric chloride in hemodialysis patients: An open-label study
por: Hsiao, Po-Jen, et al.
Publicado: (2016)

Evaluation of the Cost of a High-Dose Intravenous Iron Protocol in a Regional Hemodialysis Program: Research Letter
por: Papini, Adam, et al.
Publicado: (2021)

Intradialytic Complement Activation Precedes the Development of Cardiovascular Events in Hemodialysis Patients
por: Poppelaars, Felix, et al.
Publicado: (2018)

REM sleep latency as an independent risk for cardiovascular events in hemodialysis patients
por: Shoji, Shigeichi, et al.
Publicado: (2021)

Circulating Neprilysin Level Predicts the Risk of Cardiovascular Events in Hemodialysis Patients
por: Hwang, Hyeon Seok, et al.
Publicado: (2021)

ESA Hyporesponsiveness Is Associated with Adverse Events in Maintenance Hemodialysis (MHD) Patients, But Not with Iron Storage
por: Kuragano, Takahiro, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1g428lll1gctm6lffloei63qjj